BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Japan

A.D.A.M. Innovations and SOPHiA GENETICS Partner to Advance AI-Driven Liquid Biopsy Cancer Testing in Japan

A.D.A.M. Innovations, Japan's leading private genetic testing company, and SOPHiA GENETICS , an AI technology company pioneering data-d...

October 17, 2025 | News

Building Biopharma Resilience: Cytiva’s Joonho Choi on the Power of Connected Ecosystems

Amid global supply chain disruptions, tightening regulations, and shifting patient needs, biopharma resilience has become both a stra...

October 15, 2025 | Interview

Renalys Pharma Completes Primary Endpoint Data Collection in Phase III Sparsentan Trial for IgA Nephropathy

Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys") announced that it has completed data collection for the primary endpoint in the Phase I...

October 13, 2025 | News

Asahi Kasei Expands Sonanos™ Portfolio with Two New Specialty Excipient Grades

Asahi Kasei, a trusted provider in healthcare materials and technology, announced that it will launch two new specialty grades in its Sonanos™ portfo...

October 13, 2025 | News

Ono Pharma Reports Positive Phase 2 Signals for ONO-2808 in Multiple System Atrophy

Efficacy signals were observed in an interim analysis of a Phase 2 clinical trial for ONO-2808, a S1P5 receptor agonist Phase 2 clinical trial was con...

October 13, 2025 | News

Celaid Therapeutics Secures ¥1.05 Billion in Series B First Close to Advance Next-Generation Stem Cell Therapies

Celaid Therapeutics Inc. announced the successful completion of the 1st Close of its Series B financing round, raising JPY 1.055 billion (US...

October 08, 2025 | News

MOLCURE and Boehringer Ingelheim Forge AI-Powered Alliance to Accelerate Antibody Drug Discovery

MOLCURE Inc. announced that it has entered into a multi-year strategic research agreement with Boehringer Ingelheim for the discovery of innovative an...

October 08, 2025 | News

Asia-Pacific Takes the Lead in Global Biopharma Resilience: Cytiva’s 2025 Index Highlights Regional Rise Amid Global Slowdown

The 2025 Global Biopharma Index released by Cytiva, a Danaher company, reveals that while the global biopharma ecosystem has experienced a modest decline i...

October 08, 2025 | Analysis

Japan’s Doctors, Inc. and Nankodo Forge Alliance to Build Next-Generation AI Medical Knowledge Platform

Doctors, Inc. (Headquarters: Minato-ku, Tokyo; President & CEO: Takao Yanagawa; hereinafter “Doctors”), a leading provider of comprehensive...

October 06, 2025 | News

Japan’s Daiichi Sankyo Expands Global R&D Footprint with New Research Institute in San Diego

Daiichi Sankyo (TSE: 4568) has established Daiichi Sankyo Research Institute in San Diego, representing the third research institute established outside of...

October 06, 2025 | News

Japan Grants National Reimbursement for MedHub-AI AutocathFFR Marking a Breakthrough in AI-Driven Coronary Physiology

MedHub-AI announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved national reimbursement for the company's Autoca...

October 06, 2025 | News

Teijin and Cell Therapies Forge a Cross-Border Alliance to Accelerate Cell and Gene Therapy Access Between Japan and Australia

As the cell and gene therapy (CGT) sector moves from scientific promise to large-scale reality, collaboration between nations with strong translational and...

October 06, 2025 | News | By arcilla.fran@biopharmaapac.com

Takeda Steps Back from Cell & Gene Therapy to Refocus on Predictable Growth

Takeda Pharmaceutical, one of the world’s most globalised pharma companies, has confirmed it will step away from in-house development of its cell and...

October 05, 2025 | News

JCR Pharmaceuticals Grants Menagen Exclusive Rights to Commercialise Fabry Therapy Across MENAT Region

JCR Pharmaceuticals Co., Ltd. a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, announced ...

October 03, 2025 | News

Stay Connected